Snowball logo
logo
ATHE_logo

Alterity Therapeutics Limited

ATHE β€’ NASDAQ
$4.54+$0.02Β  (0.44%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20222023202420252026TTM
Revenue
Total revenue
5.1235253.9163334.0192855.438918--
COGS
0.3646650.2850670.2143040.1275230.113010.242807
Gross Profit
4.758863.6312663.8049815.311395(0.11301)5.19611
Operating Expenses & Income
Operating Income
(15.5)(14.64)(19.6)(14.57)(27.8)(42.97)
Total Operating Expenses
20.2618.2423.4119.8927.6948.17
R&D Expenses
14.7513.218.6414.417.2432.03
Selling General & Admin Expenses
5.4345864.9879374.7723175.48139910.415.481399
Earnings from Continuing Operations
Interest Expense
(0.002504)-----
Interest Income
0.0025040.01640.2684190.4462911.716656-
Income Tax Expense
0.070.1044590.04610.0681(3.420113)(4.994726)
Net Income
Net Income
(12.85)(13.81)(19.12)(12.15)(22.89)(35.57)
Supplemental
EBIT
(17.45)(14.64)(19.61)(14.66)(27.8)(43.06)
EBITDA
(17.39)(14.6)(19.57)(14.63)(27.69)(42.92)
In millions of USD, except % and values per 1 share